About the webinar
Rapid diagnostic test experts have prepared for years to position the industry so they can rapidly respond to an outbreak such as COVID-19. The challenges around infrastructure have helped the industry refine their response and processes, so in case of another such outbreak, rapid diagnostics will be better prepared.
In this webinar, we’ll go over the fundamentals of lateral flow devices, take you through how a simple lateral flow device is created, and discuss development timeline. Finally, we will address the industry's response to the COVID-19 pandemic.
Join this session to learn more about rapid diagnostic tests development and discover Ahlstrom-Munksjö's wide range of components for LFIA.
Meet the speakers
Stephanie Pigeot-Remy, Ph.D., Product Manager Life Sciences AHLSTROM-MUNKSJÖ
Stephanie Pigeot-Rémy holds a Ph.D. in Chemistry and Microbiology from Lyon 1 University. After a post-doctoral fellowship at the Collège de France, she joined Ahlstrom-Munksjö in 2014. She has over 15 years of experience in developing innovative products and new strategic businesses in Life Sciences and Diagnostics.
Brendan O’ Farrell, PhD., President and Founding Partner DCN Dx
Dr. O’Farrell is the president and founding partner of DCN Dx, and has worked in the rapid diagnostics field for over 20 years.
Patrick Vaughan, Chief Operating Officer DCN Dx
Patrick joined DCN in 2015. His primary responsibilities are R&D operations, client management, business and strategy development.